These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes. Nokin P, Clinet M, Beaufort P, Meysmans L, Laruel R, Chatelain P. J Pharmacol Exp Ther; 1990 Nov 15; 255(2):600-7. PubMed ID: 2147036 [Abstract] [Full Text] [Related]
7. CP-060S interacts with three principal binding sites on the L-type Ca2+ channel. Suzuki Y, Tamura K, Adachi Y, Fukazawa M, Kato T. Eur J Pharmacol; 1998 Jan 26; 342(2-3):347-51. PubMed ID: 9548407 [Abstract] [Full Text] [Related]
14. Effects of four diltiazem stereoisomers on binding of d-cis-[3H]diltiazem and (+)-[3H]PN200-110 to rabbit T-tubule calcium channels. Ikeda S, Oka J, Nagao T. Eur J Pharmacol; 1991 Nov 13; 208(3):199-205. PubMed ID: 1663043 [Abstract] [Full Text] [Related]
17. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists. Glossmann H, Linn T, Rombusch M, Ferry DR. FEBS Lett; 1983 Aug 22; 160(1-2):226-32. PubMed ID: 6309565 [Abstract] [Full Text] [Related]
18. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes. Galizzi JP, Fosset M, Lazdunski M. Biochem Biophys Res Commun; 1985 Oct 15; 132(1):49-55. PubMed ID: 2998366 [Abstract] [Full Text] [Related]